At MedStar Pituitary Center, we not only use the most innovative technology available today, but we are also actively involved in researching better treatment options for the future.
Joseph Verbalis, MD, an internationally recognized leader in pituitary tumor research, is the principal investigator of our lab and of the Georgetown-Howard Universities Center for Clinical and Translational Science
Much of the current research in the field is happening right here at our program. Our physicians are both excellent clinicians and forward-thinking researchers. We have:
The MedStar Pituitary Center team is involved in research focusing on molecular diagnostic procedures. After we remove the tumor, we examine and analyze its molecular structure. This can help us determine if further treatment is necessary. Molecular diagnosis also helps us more accurately predict your prognosis and if the tumor will recur.
Because we do such a high volume of pituitary tumor surgeries, we are able to collect a large amount of tumor data. This is crucial advancing the future of treatments for pituitary tumors.
The Grace Study, a clinical research study, is now recruiting adults ages 18 to 80 who have been diagnosed with Cushing syndrome. The purpose of the study is to determine the effectiveness and safety of an investigational study medicine on the signs and symptoms associated with Cushing syndrome.
Individuals will be evaluated to determine their eligibility to participate in the study. Each patient who qualifies will receive the investigational study medicine, study-related medical exams, and laboratory tests at no cost.
To learn more, click here.
To make an appointment, or for more information, contact us at 844-PITUITARY (748-8482).